![33964148_28_10_2022_2 [Converted]-01-01.png](https://static.wixstatic.com/media/6ef6c7_5f544a22d3e44e38864a07b9d0a57a38~mv2.png/v1/fill/w_49,h_5,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_auto/6ef6c7_5f544a22d3e44e38864a07b9d0a57a38~mv2.png)
Technology
Our Products
Previously funded under Defense Health Agency (DHA) Phase I, Phase II, and Phase IIE SBIR awards, two separate Joint Program Committee
Under previous Phase I and Phase II SBIR funding awards through the Defense Health Agency (DHA), and under current FY21 DHA J9 Phase II
_JPG.jpg)
Under prior funding from the US Army Medical Materiel Development Activity (USAMMDA) through an Other Transaction Agreement with Military
Recipient of the MTEC 2020 Prototype of the Year Award, this program is funded by the U.S. Army Medical Materiel Development Activity (USAMMDA),
Previously funded under Defense Health Agency (DHA) Phase I, Phase II, and Phase IIE SBIR awards, FY18 Joint Warfighter Medical Research Program
Under a previous Phase I SBIR award and under current Phase II SBIR funding from the US Army, Critical Innovations is currently developing Succor™ for
Previously funded under Defense Health Agency (DHA) Direct-to-Phase II and Phase IIE SBIR awards, and currently funded under both DHA Sequential
Funded by the JPC-2/Military Infectious Diseases Research Program through an Other Transaction Agreement with Military Technology Enterprise
Previously funded under a Chemical and Biological Defense Program (CBDP) Phase I SBIR award and currently under CBDP Phase II SBIR funding, Critical
Critical Innovations has been developing this innovative technology under previous Defense Health Agency (DHA) Phase I SBIR funding, as well as
Under US Space Force Direct-to-Phase II SBIR funding, Critical Innovations is developing the Fully-Qualified Manufacturing™ (FQM™)
- CAUTION -
All medical technologies listed on this page are INVESTIGATIONAL and NOT AVAILABLE FOR COMMERCIAL SALE. These statements have NOT been evaluated by the Food and Drug Administration and these technologies are NOT currently approved for human use.
CD010 Rev.L 2024-03-15